Aziz Karaoğlu

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats

Mustafa Nazıroğlu, Aziz Karaoğlu, Asude Aksoy · Toxicology · 2003 · 368 citations

Selenium Deficiency, Medicine, Liver Physiology +10

Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats

Ahmet Ateşşahín, Seval Yılmaz, İzzet Karahan et al. · Toxicology · 2005 · 302 citations

Cisplatin-induced Nephrotoxicity, Medicine, Lipid Peroxidation +6

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

Nefsal Mar, Bilge Aygen, Mehmet Ferit Gürsu et al. · BMC Cancer · 2007 · 120 citations · Full text

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 69 citations · Full text

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +7